目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GLOBAL PNEUMONIA TESTING MARKET, BY PRODUCT TYPE
6.1. Overview
6.2. Consumable
6.3. Analyzer

7. GLOBAL PNEUMONIA TESTING MARKET, BY TECHNOLOGY
7.1. Overview
7.2. Enzyme-Linked Immunosorbent Assay (ELISA)
7.3. Immunofluroscence
7.4. Immunohistochemistry (IHC)
7.5. Polymerase Chain Reaction (PCR)
7.6. Others

8. GLOBAL PNEUMONIA TESTING MARKET, BY METHOD TYPE
8.1. Overview
8.2. Immunodiagnostic
8.3. Molecular Diagnostic
8.4. Point-of-Care (POC) Testing

9. GLOBAL PNEUMONIA TESTING MARKET, BY END USER
9.1. Overview
9.2. Hospitals
9.3. Diagnostic Centers
9.4. Others

10. GLOBAL PNEUMONIA TESTING MARKET, BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America

11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Pneumonia Testing Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Pneumonia Testing Market,
11.7. Key developments and Growth Strategies
11.7.1. New Technology Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2023
11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES
12.1. Bio-Rad Laboratories, Inc.
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Abbott
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. BioMérieux SA
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. MERIDIAN BIOSCIENCE
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. HOLOGIC INC
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Becton, Dickinson and Company
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. CURETIS
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. THERMO FISHER SCIENTIFIC
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Quidel Corporation
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Products Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies

13. APPENDIX
13.1. References
13.2. Related Reports

LIST OF TABLES
TABLE 1 GLOBAL PNEUMONIA TESTING MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL PNEUMONIA TESTING MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 11 US: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 12 US: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 13 US: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 14 US: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 15 CANADA: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 16 CANADA: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 17 CANADA: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 18 CANADA: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 4 EUROPE: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 7 GERMANY: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 8 GERMANY: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 10 FRANCE: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 11 FRANCE: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 12 FRANCE: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 13 ITALY: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 14 ITALY: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 15 ITALY: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 16 ITALY: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 17 SPAIN: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 18 SPAIN: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 19 SPAIN: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 20 SPAIN: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 21 UK: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 22 UK: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 23 UK: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 24 UK: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 25 REST OF EUROPE: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 26 REST OF EUROPE: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 27 REST OF EUROPE: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 28 REST OF EUROPE: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 29 ASIA-PACIFIC: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 30 ASIA-PACIFIC: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 31 ASIA-PACIFIC: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 32 ASIA-PACIFIC: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 33 JAPAN: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 34 JAPAN: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 35 JAPAN: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 36 JAPAN: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 37 CHINA: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 38 CHINA: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 39 CHINA: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 40 CHINA: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 41 INDIA: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 42 INDIA: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 43 INDIA: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 44 INDIA: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 45 AUSTRALIA: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 46 AUSTRALIA: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 47 AUSTRALIA: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 48 AUSTRALIA: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 49 SOUTH KOREA: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 50 SOUTH KOREA: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 51 SOUTH KOREA: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 52 SOUTH KOREA: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 53 REST OF ASIA-PACIFIC: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 54 REST OF ASIA-PACIFIC: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 55 REST OF ASIA-PACIFIC: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 56 REST OF ASIA-PACIFIC: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 57 REST OF THE WORLD: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 58 REST OF THE WORLD: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 59 REST OF THE WORLD: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 60 REST OF THE WORLD: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 61 MIDDLE EAST: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 62 MIDDLE EAST: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 63 MIDDLE EAST: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 64 MIDDLE EAST: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 65 AFRICA: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 66 AFRICA: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 67 AFRICA: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 68 AFRICA: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 69 LATIN AMERICA: PNEUMONIA TESTING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 70 LATIN AMERICA: PNEUMONIA TESTING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 71 LATIN AMERICA: PNEUMONIA TESTING MARKET, BY METHOD TYPE, 2019-2032 (USD BILLION)
TABLE 72 LATIN AMERICA: PNEUMONIA TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PNEUMONIA TESTING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PNEUMONIA TESTING MARKET
FIGURE 4 GLOBAL PNEUMONIA TESTING MARKET, SHARE (%), BY PRODUCT TYPE, 2023
FIGURE 5 GLOBAL PNEUMONIA TESTING MARKET, SHARE (%), BY TECHNOLOGY, 2023
FIGURE 6 GLOBAL PNEUMONIA TESTING MARKET, SHARE (%), BY METHOD TYPE, 2023
FIGURE 7 GLOBAL PNEUMONIA TESTING MARKET, SHARE (%), BY END USER, 2023
FIGURE 8 GLOBAL PNEUMONIA TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 NORTH AMERICA: PNEUMONIA TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 EUROPE: PNEUMONIA TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 ASIA-PACIFIC: PNEUMONIA TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 REST OF THE WORLD: PNEUMONIA TESTING MARKET, SHARE (%), BY REGION, 2023
FIGURE 13 GLOBAL PNEUMONIA TESTING MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 14 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS
FIGURE 16 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 ABBOTT: SWOT ANALYSIS
FIGURE 18 BIOMÉRIEUX SA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 BIOMÉRIEUX SA: SWOT ANALYSIS
FIGURE 20 MERIDIAN BIOSCIENCE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 MERIDIAN BIOSCIENCE: SWOT ANALYSIS
FIGURE 22 HOLOGIC INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 HOLOGIC INC.: SWOT ANALYSIS
FIGURE 24 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
FIGURE 26 CURETIS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 CURETIS: SWOT ANALYSIS
FIGURE 28 THERMO FISHER SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS
FIGURE 30 QUIDEL CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 QUIDEL CORPORATION: SWOT ANALYSIS